Effect Aflibercept on Ocular Perfusion

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

March 20, 2018

Study Completion Date

May 18, 2018

Conditions
Macular DegenerationAnti Vascular Endothelial Growth Factor
Interventions
DRUG

Aflibercept Injection [Eylea]

After instillation of topical anesthetic, sterilization of the eyelid, and instillation of 1.25% povidone-iodine drops, 2.0 mg/0.05 mL of aflibercept (Eylea) is injected into the vitreous cavity through a standard pars plana approach (3.5 mm posterior to the limbus) under sterile conditions

Trial Locations (1)

4020

Department of Ophthalmology, Kepler University Hospital, Linz

All Listed Sponsors
lead

Augenabteilung Allgemeines Krankenhaus Linz

OTHER

NCT03804099 - Effect Aflibercept on Ocular Perfusion | Biotech Hunter | Biotech Hunter